It was found that all doses were superior to placebo in improving sleep in a dose-dependent manner and 40 mg showed a trend toward significance in improving depressive symptoms.
← all excerpts
Pharmacological Monotherapy for Depressive Disorders: Current and Future-A Narrative Review.
1
—
—